Related references
Note: Only part of the references are listed.Long-term effectiveness of add-on perampanel in patients with Lennox-Gastaut syndrome: A multicenter retrospective study
Sara Matricardi et al.
EPILEPSIA (2023)
Effectiveness and tolerability of adjunctive perampanel in the treatment of pediatric patients with uncontrolled epilepsy: A retrospective, single-center, real-world study
Li Gao et al.
EPILEPSY & BEHAVIOR (2022)
Landscape of childhood epilepsies-A multi-ethnic population-based study
Ruba Benini et al.
EPILEPSY RESEARCH (2022)
Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
Dan Li et al.
FRONTIERS IN NEUROLOGY (2022)
Effectiveness and safety of perampanel as adjunctive therapy among Chinese patients with focal-onset epilepsy: A real-world prospective observational study
Qinyue Wang et al.
EPILEPSY & BEHAVIOR (2022)
Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice
Pablo Alonso-Singer et al.
EPILEPSY & BEHAVIOR (2022)
Effectiveness of perampanel in the treatment of pediatric patients with focal epilepsy and ESES: A single-center retrospective study
Tao Yu et al.
FRONTIERS IN PHARMACOLOGY (2022)
A retrospective, real-world experience of perampanel monotherapy in patient with first new onset focal seizure: A Thailand experience
Yotin Chinvarun
EPILEPSIA OPEN (2022)
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up
Mariana Fernandes et al.
EPILEPSY & BEHAVIOR (2021)
Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study)
Takamichi Yamamoto et al.
EPILEPSIA OPEN (2020)
Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy
Nobutsune Ishikawa et al.
EPILEPSY & BEHAVIOR (2019)
An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
Blandine Dozieres-Puyravel et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics
Kuang-Lin Lin et al.
EPILEPSY & BEHAVIOR (2018)
A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy
Antonio Gil-Nagel et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
Zhibin Chen et al.
JAMA NEUROLOGY (2018)
Use of perampanel in children and adolescents with Lennox-Gastaut Syndrome
Stephane Auvin et al.
EPILEPSY & BEHAVIOR (2017)
Adverse effects and safety profile of perampanel: A review of pooled data
Fergus Rugg-Gunn
EPILEPSIA (2014)
Pharrnacotherapy of focal epilepsy
Anand Iyer et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials
Pritesh N. Bodalia et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
Bernhard J. Steinhoff et al.
EPILEPSIA (2013)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
Novel treatment options for epilepsy: Focus on perampanel
V. Franco et al.
PHARMACOLOGICAL RESEARCH (2013)